Everence Capital Management’s Colgate-Palmolive CL Stock Holding History

Everence Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.17M	Sell	25,524 -4,427	-15%	-$395K	0.13%	143
2025 Q4	$2.37M	Sell	29,951 -10,879	-27%	-$853K	0.14%	122
2025 Q3	$3.26M	Buy	40,830 +11,013	+37%	+$939K	0.2%	96
2025 Q2	$2.71M	Buy	29,817 +5,880	+25%	+$537K	0.17%	109
2025 Q1	$2.24M	Buy	23,937 +3,150	+15%	+$282K	0.15%	121
2024 Q4	$1.89M	Buy	20,787 +1,190	+6%	+$114K	0.12%	138
2024 Q3	$2.03M	Hold	19,597	–	–	0.13%	142
2024 Q2	$1.8K	Hold	19,597	–	–	0.12%	151
2024 Q1	$1.76K	Hold	19,597	–	–	0.12%	156
2023 Q4	$1.56M	Buy	19,597 +4,820	+33%	+$362K	0.11%	171
2023 Q3	$1.05K	Sell	14,777 -430	-3%	-$32.2K	0.08%	200
2023 Q2	$1.13M	Hold	15,207	–	–	0.09%	189
2023 Q1	$1.14K	Hold	15,207	–	–	0.09%	189
2022 Q4	$1.2K	Sell	15,207 -2,760	-15%	-$207K	0.1%	182
2022 Q3	$1.26M	Buy	17,967 +3,690	+26%	+$289K	0.12%	154
2022 Q2	$1.14M	Buy	14,277 +3,690	+35%	+$289K	0.1%	170
2022 Q1	$803K	Sell	10,587 -20,940	-66%	-$1.66M	0.06%	253
2021 Q4	$2.69M	Buy	31,527 +21,670	+220%	+$1.69M	0.2%	90
2021 Q3	$745K	Hold	9,857	–	–	0.06%	259
2021 Q2	$802K	Hold	9,857	–	–	0.07%	239
2021 Q1	$777K	Hold	9,857	–	–	0.07%	227
2020 Q4	$843K	Sell	9,857 -13,538	-58%	-$1.12M	0.08%	203
2020 Q3	$1.8M	Sell	23,395 -2,760	-11%	-$210K	0.2%	94
2020 Q2	$1.89M	Buy	26,155 +3,410	+15%	+$242K	0.22%	80
2020 Q1	$1.51M	Buy	22,745 +12,100	+114%	+$853K	0.21%	81
2019 Q4	$733K	Sell	10,645 -9,372	-47%	-$639K	0.11%	199
2019 Q3	$1.47M	Hold	20,017	–	–	0.24%	94
2019 Q2	$1.44M	Hold	20,017	–	–	0.24%	98
2019 Q1	$1.37M	Buy	20,017 +3,040	+18%	+$196K	0.24%	97
2018 Q4	$1.01M	Hold	16,977	–	–	0.23%	109
2018 Q3	$1.14M	Hold	16,977	–	–	0.23%	116
2018 Q2	$1.1M	Hold	16,977	–	–	0.23%	113
2018 Q1	$1.22M	Hold	16,977	–	–	0.27%	101
2017 Q4	$1.28M	Sell	16,977 -9,406	-36%	-$687K	0.28%	95
2017 Q3	$1.92M	Hold	26,383	–	–	0.44%	58
2017 Q2	$1.96M	Hold	26,383	–	–	0.48%	47
2017 Q1	$1.93M	Buy	26,383 +6,250	+31%	+$437K	0.51%	47
2016 Q4	$1.32M	Sell	20,133 -3,057	-13%	-$210K	0.38%	76
2016 Q3	$1.72M	Hold	23,190	–	–	0.51%	50
2016 Q2	$1.7M	Hold	23,190	–	–	0.52%	49
2016 Q1	$1.64M	Hold	23,190	–	–	0.51%	52
2015 Q4	$1.54M	Buy	23,190 +1,980	+9%	+$132K	0.5%	52
2015 Q3	$1.35M	Buy	21,210 +2,679	+14%	+$175K	0.46%	56
2015 Q2	$1.21M	Hold	18,531	–	–	0.39%	69
2015 Q1	$1.31M	Hold	18,531	–	–	0.44%	58
2014 Q4	$1.28M	Buy	18,531 +2,481	+15%	+$168K	0.44%	57
2014 Q3	$1.04M	Hold	16,050	–	–	0.38%	80
2014 Q2	$1.09M	Hold	16,050	–	–	0.41%	70
2014 Q1	$1.04M	Hold	16,050	–	–	0.41%	69
2013 Q4	$1.05M	Hold	16,050	–	–	0.42%	69
2013 Q3	$952K	Hold	16,050	–	–	0.41%	72
2013 Q2	$920K	Buy	+16,050	New	+$953K	0.42%	71

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Everence Capital Management's CL Position: Q1 2026 in Review

Everence Capital Management reduced its Colgate-Palmolive (CL) stake by 15% in Q1 2026, selling an estimated $395K and leaving 25,524 shares worth $2.17M. The position accounts for 0.13% of the portfolio, ranked #143.

Everence Capital Management first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.26M in Q3 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Everence Capital Management held 25,524 shares of Colgate-Palmolive worth $2.17M as of Q1 2026.
Everence Capital Management sold 4,427 Colgate-Palmolive shares in Q1 2026, an estimated $395K.
Colgate-Palmolive made up 0.13% of Everence Capital Management's portfolio in Q1 2026, its #143 holding.
Everence Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
Everence Capital Management's Colgate-Palmolive position peaked at $3.26M in Q3 2025.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.